Gordon Rees Scully Mansukhani New York Founding Partner Mercedes Colwin has been named the 2026 recipient of the Alvin Levine Award by NephCure, a non-profit organization dedicated to supporting patients with rare kidney diseases.
The Alvin Levine Award recognizes individuals whose leadership, advocacy, and contributions advance NephCure’s mission to find better treatments and a cure for rare, protein-spilling kidney diseases. Colwin was selected for her dedication to using her voice and influence within the legal profession and beyond to make a meaningful impact in the lives of patients and families affected by these conditions.
An accomplished trial attorney with a success rate of more than 90% in trials and arbitrations, Colwin is renowned for her relentless advocacy and outstanding legal acumen across various litigation areas, including employment law, commercial litigation, and class actions. In addition to her legal achievements, she has been recognized by Forbes Business American Airlines as one of the six most influential women in America. She has also received the Graciela Olivarez Award from Notre Dame Law School, an honor shared with Supreme Court Justice Sonia Sotomayor. Regarded as a top national legal analyst, she regularly appears on television to discuss critical legal issues making headline news.
Colwin will receive the award at NephCure’s 2026 Countdown to a Cure Gala, which will take place in New York City on November 12, 2026.
Learn more and register on NephCure’s website to attend the event.
